BSE filing, BSE: 544013. Summary written from the filing by ALFA Finder's alert engine.
KK Shah Hospitals Ltd: key numbers
- Share price
- ₹45.00
- Market cap
- ₹30.64 Cr
- Revenue (annual)
- ₹9.43 Cr
- Net profit (annual)
- ₹-0.62 Cr
- P/E (TTM)
- -49.2×Sector 34.1×
- Promoter holding
- 71.36%
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from KK Shah Hospitals Ltd
All →KK Shah Hospitals Board Meeting Date
KK Shah Hospitals Limited scheduled a board meeting on October 29, 2026, to consider and approve the unaudited financial results for the half year ended September 30, 2026.
KK Shah Hospitals Annual General Meeting
KK Shah Hospitals Ltd announced the voting results for its Annual General Meeting held on August 18, 2026. All proposed resolutions were passed by shareholders.
KK Shah Hospitals Annual General Meeting
KK Shah Hospitals Limited conducted its 4th Annual General Meeting on August 18, 2026. Shareholders considered the adoption of annual accounts and the re-appointment of directors.
KK Shah Hospitals Annual Report
KK Shah Hospitals Ltd has submitted its Annual Report for the financial year 2025-26 and the notice for its 4th Annual General Meeting.
KK Shah Hospitals Annual General Meeting
KK Shah Hospitals Limited announced its board meeting outcome, which included the approval of the Director's Report and scheduling its 4th Annual General Meeting for August 2026.
KK Shah Hospitals Business Update
KK Shah Hospitals installed a GE Revolution Evo 64‑slice cardiac CT scanner in Ratlam. A Siemens 1.5T MRI will be commissioned shortly, broadening diagnostic services.
Other other announcement announcements
All →Mahindra & Mahindra Financial Services Other Announcement
Mahindra & Mahindra Financial filed its ALM statement as of September 30, 2026, submitted to RBI. It is a periodic regulatory return with no new transaction.
ACME Solar Holdings Other Announcement
ACME Solar filed the CARE Ratings monitoring agency report on its Rs.2,800 crore QIP for the quarter ended 30 September 2026. The report shows no deviation from the offer objects.
eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.